Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002785 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
A Phase 2 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002785: Completed Phase 2 study, sponsored by Children's Oncology Group.
NCT00002785 is a Phase 2 study that has completed, run by Children's Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002785, a Phase 2 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Bone marrow transplantation may allow the doctor to give higher doses of chemotherapy and kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, bone marrow transplantation, and radiation therapy in treating infants with acute lymphoblastic leukemia.
Interventions
- DRUG cyclophosphamide
- BIOLOGICAL filgrastim
- DRUG cytarabine
- DRUG cyclosporine
- DRUG asparaginase
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-07 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
What the finished NCT00002785 record still lists
NCT00002785 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which cyclophosphamide is the first listed.
NCT00002785 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002785 about?
NCT00002785 is a clinical study titled "Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia". RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Bone marrow transplantation may allow the doctor to give higher doses of chemotherapy and kill more cancer cells. Radiatio...
What is the current status of trial NCT00002785?
This trial is currently completed. It is a Phase 2 study. The study started on 1996-07. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00002785?
The interventions under investigation include: cyclophosphamide (DRUG), filgrastim (BIOLOGICAL), cytarabine (DRUG), cyclosporine (DRUG), asparaginase (DRUG).
Who is sponsoring clinical trial NCT00002785?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia